Rob Capone

Rob Capone is a Partner at Telegraph Hill Partners based in Research Triangle Park, North Carolina. He manages investments through the firm's $525 million fifth fund and represents Telegraph Hill Partners on the boards of Cell Microsystems, Emerging Therapy Solutions, and Panome Bio. Prior to his current role, Capone spent a decade as a strategy consultant, culminating in his position as a Partner at Trinity Life Sciences where he advised emerging biotech and medtech companies. His earlier career includes four years as an Associate at Telegraph Hill Partners and analyst experience at Seven Hill Partners, complemented by a finance degree from the University of Notre Dame and an MBA from UC Berkeley's Haas School of Business. Capone currently focuses on growth equity investments across the life science tools, medical device, and healthcare technology sectors.